相关实验视频
Updated: Jan 13, 2026

03:25
Simple Continuous Glucose Monitoring in Freely Moving Mice
Published on: February 24, 2023
7.6K
在非胰岛素治疗的2型糖尿病患者中,持续监测血糖以控制血糖水平
Nahid Karimi1,2, Sarah E Choi2, Yeonsu Song2,3,4
1Keck-University of Southern California Internal Medicine Outpatient Clinic, California.
Journal of the American Association of Nurse Practitioners
|January 7, 2026
概括
持续血糖监测 (CGM) 在非胰岛素药物治疗的2型糖尿病 (T2D) 患者中改善了血糖控制. 持续的好处取决于一致的使用和个性化的支持,强调执业护士的作用.
科学领域:
- 内分泌学 在内分泌学.
- 糖尿病管理 糖尿病管理
- 提高质量 提高科学 提高质量
背景情况:
- 持续的葡萄糖监测 (CGM) 与不接受胰岛素治疗的2型糖尿病 (T2D) 患者的更好的血糖控制有关.
- 在内分泌学诊所采用CGM仍然不够理想.
- 该项目解决了洛杉矶县内分泌学实践中对T2D患者的CGM有限使用问题.
研究的目的:
- 探索CGM在非胰岛素治疗的T2D患者中的使用.
- 评估在内分泌学诊所环境中采用CGM的可行性.
- 评估CGM对血糖控制和时间范围 (TIR) 的影响.
主要方法:
- 对2型糖尿病患者血红蛋白A1c (HbA1c) >7%的非胰岛素患者的回顾性图表审查.
- 纳入标准:符合血糖和治疗标准的成年人 (≥18岁).
- 在6个月内对HbA1c和TIR变化进行描述性统计和中断时间序列分析.
主要成果:
- 9名患者中有8名在CGM使用6个月后实现了HbA1c降低 (≥0.3%).
- 一名患者在适当使用设备时,TIR显著增加 (≥8%).
- 间断时间序列分析表明,在CGM启动后,HbA1c立即降低.
结论:
- 服用非胰岛素药物的T2D患者可以成功地启动和使用CGM.
- 发现了早期的HbA1c改善,但持续的结果需要持续的CGM磨损和坚持.
- 执业护士对于通过教育和综合护理促进持续使用CGM至关重要.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes: Management and Pharmacotherapy
858
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
858
Hypoglycemia and Glucagon
822
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
822
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Glucose Homeostasis: Regulation of Blood Glucose
3.8K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
3.8K
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K

